Updated on 2024/05/25

写真a

 
Saiki Masafumi
 
Organization
Graduate Faculty of Interdisciplinary Research Faculty of Medicine Clinical Medicine (Respiratory Medicine) Assistant Professor
Title
Assistant Professor

Degree

  • 学士(医学) ( 山梨大学 )

Papers

  • The First Case Report of Effective Treatment With Sotorasib for Metastatic Atypical Lung Carcinoid Harboring KRAS G12C Mutation and Aggressive Disseminated Lung Metastasis: A Case Report Reviewed

    Masafumi Saiki 1, Chisa Omori 1, Honami Morikawa 1, Ken Shinohara 1, So Shimamura 1, Hiroki Ohkoshi 1, Yoshinori Uchida 1, Tomohiro Inoue 2, Tetsuo Kondo 2, Shinnosuke Ikemura 1, Kenzo Soejima

    JTO clinical and research reports   2023.12

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  • Subsequent treatment for locally advanced non-small-cell lung cancer that progressed after definitive chemoradiotherapy and consolidation therapy with durvalumab: a multicenter retrospective analysis (TOPGAN 2021-02) Reviewed

    2023.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  • Clinical efficacy of amrubicin in patients with small cell lung cancer relapse after first-line treatment including immune checkpoint inhibitors: A retrospective multicenter study (TOPGAN 2021-01) Reviewed

    Thoracic Cancer   2023.1( ISSN:1759-7706 )

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  • A case of non-neutropenic invasive pulmonary aspergillosis under immune checkpoint inhibitor therapy for malignant melanoma Reviewed

    Respiratory Medicine Case Reports   2022.3( ISSN:2213-0071 )

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  • Dramatic response to alectinib in an ALK-positive LCNEC patient with a poor performance status: A case report Reviewed

    Respirology Case Reports   2021.8

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

  • Significant therapeutic effectiveness of durvalumab after chemoradiotherapy for a patient with post-operative recurrent pulmonary pleomorphic carcinoma Reviewed

    Respirology Case Reports   2021.3( ISSN:2051-3380 )

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

  • Myositis induced by durvalumab in a patient with non-small cell lung cancer: A case report Reviewed

    Thoracic Cancer   2020.12( ISSN:1759-7706 )

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

  • Barcode sequencing identifies resistant mechanisms to epidermal growth factor receptor inhibitors in circulating tumor DNA of lung cancer patients Reviewed

    CANCER SCIENCE   2019.11( ISSN:1347-9032 )

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  • Coexistence of dementia with smear-positive pulmonary tuberculosis is associated with patient in-hospital mortality Reviewed

    Respiratory Investigation   2019.7( ISSN:2212-5353 )

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  • Correlation between serum adenosine deaminase activity and efficacy of anti-programmed cell death-1 antibody Reviewed

    LUNG CANCER   2019.7( ISSN:0169-5002 )

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  • Correlation between thyroid transcription factor-1 expression, immune-related thyroid dysfunction, and efficacy of anti-programmed cell death protein-1 treatment in non-small cell lung cancer Reviewed

    Journal of Thoracic Disease   2019.5( ISSN:2072-1439 )

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  • Improvement in the survival of patients with stage IV non-small-cell lung cancer: Experience in a single institutional 1995-2017 Reviewed

    LUNG CANCER   2019.5( ISSN:0169-5002 )

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  • Characterization of Computed Tomography Imaging of Rearranged During Transfection-rearranged Lung Cancer Reviewed

    Clinical Lung Cancer   2018.9( ISSN:1525-7304 )

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  • High ratio of T790M to EGFR activating mutations correlate with the osimertinib response in non-small-cell lung cancer Reviewed

    LUNG CANCER   2018.3( ISSN:0169-5002 )

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  • EGFR T790M mutation after chemotherapy for small cell lung cancer transformation of EGFR-positive non-small cell lung cancer Reviewed

    Respiratory Medicine Case Reports   2018.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  • Dramatic response to alectinib in inflammatory myofibroblastic tumor with anaplastic lymphoma kinase fusion gene Reviewed

    JAPANESE JOURNAL OF CLINICAL ONCOLOGY   2017.12( ISSN:0368-2811 )

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

▼display all

Presentations

  • 根治的化学放射線療法とdurvalumab後に病状進行した局所進行非小細胞肺癌の次治療検討(TOPGAN2021-02)

    第63回日本肺癌学会学術集会  2022.12 

     More details

    Event date: 2022.12

    Language:Japanese   Presentation type:Oral presentation(general)  

  • Pembrolizumab投与後早期にRamsay-Hunt症候群を発症した一例

    第 63 回日本肺癌学会学術集会  2022.12 

     More details

    Event date: 2022.12

    Language:Japanese   Presentation type:Poster presentation  

  • 当院における高齢進行型小細胞肺癌患者に対するICI併用レジメンの後方視的検討

    第 63 回日本肺癌学会学術集会  2022.12 

     More details

    Event date: 2022.12

    Language:Japanese   Presentation type:Oral presentation(general)  

Guidance results

  • 2022

    Type:Achievement of hospital training physicians guidance

    Number of people receiving guidance :29people